EWS & EVENTS
He Beat Lymphoma at 31, While Pioneering Breakthroughs in Cancer Research

Click on "Read More" to get to the full article

Read the full article  
MIGHT ALSO LIKE
YOU MIGHT ALSO LIKE
Agonist Redirected Checkpoint Platform (ARC); Engineering Bi-Functional Fusion Proteins (PD1-Fc-OX40L), for Cancer Immunotherapy

SITC 2018

Read more
Shattuck Labs, Inc. Announces Initiation of Phase 1 Clinical Trial of SL-279252 (PD1/OX40L)

Shattuck Labs Press Release May 6, 2019  

Read more